Apoptosis: New insights in transfusion immunobiology;Apoptosi: Nuove osservazioni e introspezioni in immunobiologia trasfusionale

Trasfusione del Sangue

Volumn 47, Issue 3, 2002, Pages 363-377

  Conte, Roberto ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645995334     PISSN: 00411787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Blumberg N, Heal JH: Immunomodulation by blood transfusion: an evolving scientific and clinical challenge. Am J Med, 101, 299, 1996. (Pubitemid 26392443)
2. Dzik S, Blajchman MA, Blumberg N et al.: Current research on the immunomodulatory effect of allogeneic blood transfusion. Vox Sang, 70, 187, 1996. (Pubitemid 26161426)
3. Houbiers JGA, Brand A, van de Watering LMG et al.: Randomised controlled trial comparing transfusion of leukocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet, 334, 841, 1996. (Pubitemid 24267215)
4. Vamvakas EC: Transfusion-associated cancer recurrence and infection: meta analysis of randomized, controlled clinical trials. Transfusion, 36, 175, 1996.
5. Blajchman MA, Dzik S, Vamvakas EC et al.: Clinical and molecular basis of transfusion-induced immunomodulation: summary of the proceedings of a state of the art conference. Transf Med Reviews, 15, 108, 2001. (Pubitemid 32303575)
6. Bordin JO, Heddle NM, Blajchman MA: Biologic effects of leukocytes present in transfused cellular blood products. Blood, 84, 1703, 1994.
7. Ghio M, Contini P, Mazzei C et al.: Soluble HLA Class I, HLA Class II, and Fas Ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusion. Blood, 93, 1770, 1999.
8. Kerr JF, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wideranging implications in tissue kinetics. Br J Cancer, 26, 239, 1972.
9. Cohen JJ: Apoptosis. Immunol Today, 14, 126, 1993.
10. Frabetti F, Musiani D, Marini M et al.: White cell apoptosis in packed red cells. Transfusion, 38, 1982, 1998.
11. Mincheff M: Changes in donor leukocytes during blood storage. Implications on post transfusion immunomodulation and transfusion-associated GVHD. Vox Sang, 74, (Suppl2), 189, 1998.
12. Frabetti F, Tazzari PL, Musiani D et al.: White cell apoptosis in platelet concentrates. Transfusion, 40, 160, 2000. (Pubitemid 30108986)
13. Martelli AM, Tazzari PL, Bortul R et al.: Nuclear matrix protein is released from apoptotic white cells during cold (1-6° C) storage of concentrated red cell units and might induce antibody response in multiply transfused patients. Transfusion, 40, 169, 2000. (Pubitemid 30108987)
14. Pistillo MP, Tazzari PL, Gaudiano C et al.: Detection of anti-CTLA-4 antibodies in sera from multiply transfused patients with hematological diseases. Transfusion, 41, 462, 2001.
15. Snyder EL, Kuter DJ: Apoptosis in transfusion medicine: of death and dying-is that all there is? Transfusion, 40, 135, 2000.
16. Clarke PGH: Development cell death: morphological diversity and multiple mechanisms. Anat Embryol, 181, 195, 1990.
17. Williams GT, Smith CA: Molecular regulation of apoptosis: genetic controls on cell death. Cell, 74, 777, 1993.
18. Steller H: Mechanisms and genes of cellular suicide. Science, 267, 1445, 1995.
19. Hengartner MO: The biochemistry of apoptosis. Nature, 407, 770, 2000.
20. Nagata S: Apoptotic DNA fragmentation. Exp Cell Res, 256, 12, 2000.
21. Kromer G, Reed JC: Mitochondrial control of cell death. Nat Med, 6, 513, 2000.
22. Zhang H, Xu Q, Krajewski S et al.: BAR: an apoptosis regulator at the intersection of caspases and Bcl-2 family proteins. PNAS, 97, 2597, 2000. (Pubitemid 30159216)
23. Los M, Wesselborg S, Schulze-Osthoff KM: The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. Immunity, 10, 629, 1999. (Pubitemid 29302916)
24. Salvesen GS, Dixit VM: Caspases: intracellular signalling by proteolysis. Cell, 91, 443, 1997.
25. Yoshida H, Kong Y-Y, Yoshida R et al.: Apaf 1 is required for mitochondrial pathways of apoptosis and brain development. Cell, 94, 739, 1998. (Pubitemid 28436006)
26. Antonsson B, Martinou JC: The Bcl-2 protein family. Exp Cell Res, 256, 50, 2000.
27. Strasser A, Harris AW, Huang DCS et al.: Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J, 14, 6136, 1995. (Pubitemid 26007301)
28. Hockenbery DM: Bcl-2 a novel regulator of cell death. Bioassays, 17, 631, 1995.
29. Nagata S: Fas and Fas ligand: a death factor and its receptor. Adv Immunol, 57, 129, 1994.
30. Suda T, Okazaki T, Naito Y et al.: Expression of the Fas ligand in cells of T cell lineage. J Immunol, 154, 3806, 1995.
31. Krammer PH: CD95 (APO-1/Fas)-mediated apoptosis: live and let die. Adv Immunol, 71, 163, 1999.
32. Herr I, Debatin KM: Cellular stress response and apoptosis in cancer therapy. Blood, 98, 2603, 2001.
33. Wyllie AH, Kerr JF, Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol, 68, 251, 1980.
34. Zhivotovsky B, Nicotera P, Bellomo G et al.: Ca2+ and endonuclease activation in radiation-induced lymphoid cell death. Cell Res, 207, 163, 1993. (Pubitemid 23192177)
35. Allen RT, Hunter WJ 3d, Agrawal DK: Morphological and biochemical characterization and analysis of apoptosis. J Pharmacol Toxicol Methods, 37, 215, 1997.
36. Nicoletti I, Migliorati G, Pagliacci MC et al.: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods, 139, 271, 1991.
37. Telford WG, King LE, Fraker PJ: Rapid quantification of apoptosis in pure and heterogeneous cell populations using flow cytometry. J Immunol Methods, 172, 1, 1994.
38. Koester SK, Roth P, Mikulka WR et al.: Monitoring early cellular responses in apoptosis is aided by the mitochondrial membrane protein-specific monoclonal antibody APO2.7. Cytometry, 29,1086, 1997. (Pubitemid 28032097)
39. Tazzari PL, Polito L, Bolognesi A et al.: Immunotoxins containing recombinant anti-CTL-4-single-chain fragment antibodies and saporin: in vitro results and in vivo effects in an acute rejection. J Immunol, 167, 4222, 2001. (Pubitemid 32954295)
40. Duriez PJ, Shah GM: Cleveage of poly (ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem Cell Biol, 75, 337, 1997.
41. Bellammy CO, Malcomson RD, Harrison et al.: Cell death in health and disease: the biology and regulation of apoptosis. Semin Cancer Biol, 6, 3, 1995.
42. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456, 1995.
43. Duke RC, Ojicius DM, Young ID: Cell suicide in health and disease. Sci Am, 275, 80, 1996.
44. Ju ST, Panka DJ, Cui H et al.: Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature, 373, 444, 1995.
45. Belkka C, Marini P, Budach W et al.: Radiation-induced apoptosis in human lymphocytes relies on the up-regulation of CD95/Fas/APO-1 ligand. Radiat Res, 149, 588, 1998.
46. Bellgrau D, Gold D, Selawry H et al.: A role for CD95 ligand in preventing graft rejection. Nature, 377, 630, 1995.
47. Griffith TS, Brunner T, Fletcher SM et al.: Fas-ligand induced apoptosis as a mechanism of immune privilege. Science, 270, 1189, 1995.
48. Chernovsky AV, Wang Y, Wong FS et al.: The role of Fas in autoimmune diabetes. Cell, 89, 17, 1997.
49. Hetts SW: To die or not to die. JAMA, 279, 300, 1998.
50. Giordano C, Stassi G, De Maria R et al.: Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science, 275, 960, 1997. (Pubitemid 27087708)
51. Rodriguez I, Matsuura K, Khatib K et al.: A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody function. J Exp Med, 183, 1031, 1996. (Pubitemid 26113967)
52. Nagle WA, Soloff BL, Moss AJ Jr, Henle KJ: Cultured Chinese hamster cells undergo apoptosis after exposure to cold but nonfreezing temperatures. Cryobiology, 27, 439, 1997.
53. Gregory CD, Milner AE: Regulation of cell survival in Burkitt lymphoma: implication from studies of apoptosis following cold-shock treatment. Int J Cancer, 57, 419, 1994.
54. Liles WC, Kiener PA, Ledbetter JA et al.: Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implication for the regulation of apoptosis in neutrophils. J Exp Med, 184, 429, 1996.
55. Bontadini A, Tazzari PL, Manfroi S et al.: Apoptosis in leucodepleted packed red blood cells. Vox Sang, 83, 35, 2002. (Pubitemid 36806497)
56. Li J, Xia Y, Bertino AM et al.: The mechanism of apoptosis in human platelets during storage. Transfusion, 40, 1320, 2000.
57. Martelli AM, Bortul R, Fackelmayer FO et al.: Biochemical and morphological characterization of the nuclear matrix from apoptotic HL-60 cells. J Cell Biochem, 72, 35, 1999. (Pubitemid 28541479)
58. Martelli AM, Cocco L, Riederer BM, Neri LM: The nuclear matrix: a critical appraisal. Histol Histopathol, 11, 1035, 1996.
59. Miller T, Beausang LA, Meneghini M Lidgard G: Death-induced changes to the nuclear matrix: the use of anti-nuclear matrix antibodies to study agents of apoptosis. Biotechniques, 15, 1042, 1993. (Pubitemid 24002555)